Cargando…

Mogrol Attenuates Osteoclast Formation and Bone Resorption by Inhibiting the TRAF6/MAPK/NF-κB Signaling Pathway In vitro and Protects Against Osteoporosis in Postmenopausal Mice

Osteoporosis is a serious public health problem that results in fragility fractures, especially in postmenopausal women. Because the current therapeutic strategy for osteoporosis has various side effects, a safer and more effective treatment is worth exploring. It is important to examine natural pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yongjie, Zhang, Linlin, Li, Zongguang, Wu, Zuoxing, Lin, Xixi, Li, Na, Shen, Rong, Wei, Guojun, Yu, Naichun, Gong, Fengqing, Rui, Gang, Xu, Ren, Ji, Guangrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038946/ https://www.ncbi.nlm.nih.gov/pubmed/35496311 http://dx.doi.org/10.3389/fphar.2022.803880

Ejemplares similares

Schmorl node induced multiple radiculopathy: A rare case report
por: Chen, Yongjie, et al.
Publicado: (2020)

A ventral midline primary schwannoma of the cervical spinal cord: A case report
por: Gong, Fengqing, et al.
Publicado: (2020)

Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
por: Boyce, Brendan F., et al.
Publicado: (2018)

Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling
por: Tomomura, Mineko, et al.
Publicado: (2015)

Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect
por: Chen, Wenkai, et al.
Publicado: (2022)

USF1-mediated upregulation of lncRNA GAS6-AS2 facilitates osteosarcoma progression through miR-934/BCAT1 axis
por: Wei, Guojun, et al.
Publicado: (2020)

Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells
por: Chen, Wenkai, et al.
Publicado: (2023)

Pharmacological Activities of Mogrol: Potential Phytochemical against Different Diseases
por: Jaiswal, Varun, et al.
Publicado: (2023)

Construction and Optimization of the de novo Biosynthesis Pathway of Mogrol in Saccharomyces Cerevisiae
por: Wang, Siyu, et al.
Publicado: (2022)

Aconine attenuates osteoclast-mediated bone resorption and ferroptosis to improve osteoporosis via inhibiting NF-κB signaling
por: Xue, Chunchun, et al.
Publicado: (2023)

Acacetin Induces Apoptosis in Human Osteosarcoma Cells by Modulation of ROS/JNK Activation
por: Wang, Shubin, et al.
Publicado: (2020)

Oxidative Stress and Bone Resorption Interplay as a Possible Trigger for Postmenopausal Osteoporosis
por: Cervellati, Carlo, et al.
Publicado: (2014)

Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2015)

Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis
por: Dempster, David W, et al.
Publicado: (2021)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
por: Yan, Liuliu, et al.
Publicado: (2019)

Up‐regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF‐κB pathway
por: Wang, Fei, et al.
Publicado: (2019)

Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF-κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis
por: Ding, Dong, et al.
Publicado: (2022)

Osteoclasts secrete osteopontin into resorption lacunae during bone resorption
por: Luukkonen, Jani, et al.
Publicado: (2019)

Microcracks and Osteoclast Resorption Activity In Vitro
por: Rumpler, Monika, et al.
Publicado: (2012)

Immune Regulation of Osteoclast Function in Postmenopausal Osteoporosis: A Critical Interdisciplinary Perspective
por: Zhao, Renqing
Publicado: (2012)

Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation
por: Wang, Jie, et al.
Publicado: (2015)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
por: Liu, Zezheng, et al.
Publicado: (2020)

The effects of seeding density and osteoclastic supplement concentration on osteoclastic differentiation and resorption
por: Remmers, Stefan J.A., et al.
Publicado: (2022)

Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis
por: Wang, Han, et al.
Publicado: (2023)

Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2021)

Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2022)

Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis
por: Zhou, Yang, et al.
Publicado: (2021)

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
por: Kong, Sung Hye, et al.
Publicado: (2022)

Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts
por: Zhang, Xiaohui, et al.
Publicado: (2011)

Septins are critical regulators of osteoclastic bone resorption
por: Møller, Anaïs M. J., et al.
Publicado: (2018)

Rab GTPases in Osteoclastic Bone Resorption and Autophagy
por: Roy, Michèle, et al.
Publicado: (2020)

Norisoboldine Suppresses Osteoclast Differentiation through Preventing the Accumulation of TRAF6-TAK1 Complexes and Activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways
por: Wei, Zhi-feng, et al.
Publicado: (2013)

Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-κB and MAPK Signaling
por: Wu, Zuoxing, et al.
Publicado: (2022)

Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways
por: Xiao, Long, et al.
Publicado: (2020)

Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model
por: Wang, Huijuan, et al.
Publicado: (2018)

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
por: Li, Xuedong, et al.
Publicado: (2021)

Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis
por: Kim, Nacksung, et al.
Publicado: (2005)

Osteoclasts and the resorption of bone by transplanted mammary carcinoma in rats.
por: O'Grady, R. L., et al.
Publicado: (1985)

Osteoclastic bone resorption directly activates osteoblast function
por: Udagawa, Nobuyuki
Publicado: (2012)

Osteoclast-independent bone resorption by fibroblast-like cells
por: Pap, Thomas, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_po8gk46bu27c747c9qbqmif0u9